| PERIOD ENDING | 30-Nov-09 | 31-Aug-09 | 31-May-09 | 28-Feb-09 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 149 | 193 | 624 | 1,003 | | Selling General and Administrative | 164 | 289 | 1,774 | 602 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 388 | 1 | 1 | 1 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (701) | (484) | (2,399) | (1,605) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (8) | 0 | 1 | 2 | | Earnings Before Interest And Taxes | (709) | (483) | (2,399) | (1,604) | | Interest Expense | 11 |
-
|
-
|
-
| | Income Before Tax | (720) | (483) | (2,399) | (1,604) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (720) | (483) | (2,399) | (1,604) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (720) | (483) | (2,399) | (1,604) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($720) | ($483) | ($2,399) | ($1,604) |
|
0.91% Nasdaq 
Income Statement
